Scopus BioPharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2020 to Q2 2023
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Scopus BioPharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q2 2023.
- Scopus BioPharma Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 39.7M shares, a 88.4% increase year-over-year.
- Scopus BioPharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 21.1M shares, a 22.3% increase from 2021.
- Scopus BioPharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 17.3M shares, a 29.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)